This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK, Nov. 11, 2013 /PRNewswire/ -- Morgan & Morgan announces that it is investigating potential legal claims against the board of directors of Santarus, Inc. ("Santarus" or the "Company") (NASDAQ: SNTS) concerning the proposed acquisition of the Company by Salix Pharmaceuticals, Ltd. ("Salix").
Under the terms of the proposed transaction, Santarus stockholders will receive
$32.00 in cash for each share of Santarus owned, valuing the transaction at approximately
If you own shares of Santarus and want more information about the
Santarus takeover investigation please contact
George Pressly, Esq. at 1(800) 631-6234 or email George at
Our investigation concerns possible breaches of fiduciary duty and other violations of law by Santarus' Board of Directors for not acting in the best interest of the Company's shareholders in connection with the sale process.
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to
securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:Morgan & Morgan
Peter Safirstein, Esq.28 West 44
th StreetSuite 2001
New York, NY 100361-800-631-6234
SOURCE Morgan & Morgan